drugset / Trial / NCT02950935
Progesterone in Threatened Abortion
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of this study will be to assess the efficacy of natural progesterone at a daily dose of 25 mg/bid in the maintenance of early pregnancy in women with symptoms of threatened abortion. The secondary objectives will be the efficacy of progesterone in reducing both pain and uterine contractions.
Timeline
- Start
- 2017-04-04
- Primary completion
- 2018-05-02
- Completion
- 2018-05-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 25 mg | Subcutaneous |